Ascletis Pharma Inc. — Board/Management Information 2018

Dec 24, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [87 x 43] intentionally omitted <==

Ascletis Pharma Inc. 歌禮製藥有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1672)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the “ Board ”) of Ascletis Pharma Inc. are set out below:

Dr. Jinzi Jason WU (Chairman, Executive Director) Ms. Judy Hejingdao WU (Executive Director) Dr. Ru Rong JI (Independent non-executive Director) Dr. Yizhen WEI (Independent non-executive Director) Mr. Jiong GU (Independent non-executive Director) Ms. Lin HUA (Independent non-executive Director)

There are three Board committees. The table below provides membership information of these committees on which each Board member serves.

	CommitteeDirectorAuditCommitteeRemunerationCommitteeNominationCommittee

Hangzhou, the People’s Republic of China December 24, 2018

As at the date of this announcement, the Board of Directors of the Company comprises Dr. Jinzi Jason WU and Mrs. Judy Hejingdao WU, as executive Directors; and Dr. Ru Rong JI, Dr. Yizhen WEI, Mr. Jiong GU and Ms. Lin HUA, as independent non-executive Directors.